HC ANDERSEN CAPITAL

Embla Medical – Presentation of Q3 2025 Interim Report

Name: Embla Medical – Presentation of Q3 2025 Interim Report
Start: 2025-10-23T10:00:00+0200
End: 2025-10-23T10:30:00+0200

AUTHOR

Mie

DATE

25. September 2025

Embla Medical – Presentation of Q3 2025 Interim Report

Embla Medical – Presentation of Q3 2025 Interim Report 23 OctoberOct 2025 10:00 - 10:30Online Event

Tilmeld

Information

Embla Medical – Presentation of Q3 2025 Interim Report 23 OctoberOct 2025 10:00 - 10:30

Embla Medical – Presentation of Q3 2025 Interim Report Online Event

Tilmeld

Agillic – Præsentation af Q3 2025 resultater

Trifork – Præsentation af Q3 2025 resultater samt Q&A

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Adviser on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

Embla Medical – Presentation of Q3 2025 Interim Report

Embla Medical – Presentation of Q3 2025 Interim Report

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital